Nektar Therapeutics (NKTR) Cash from Operations (2010 - 2026)
Nektar Therapeutics' quarterly Cash from Operations came in at 44298000.0 in Q1 2026, up 9.69% year-on-year from 40383396.41 in Q1 2025, and up 31.81% quarter-over-quarter from 64959000.0 in Q4 2025.
Nektar Therapeutics has reported Cash from Operations for 17 years, with the latest figure at 44298000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 9.69% year-over-year to 44298000.0; the trailing twelve-month figure through Mar 2026 stood at 203756000.0 (down 15.2% YoY), and the FY2025 full-year result was 208511000.0, down 18.67% from the prior year.
- Cash from Operations for Q1 2026 stood at 44298000.0, up from 64959000.0 in the prior quarter.
- The five-year high for Cash from Operations was 37702000.0 in Q2 2024, with the low at 88424000.0 in Q1 2022.
- Average Cash from Operations over 5 years is 54419470.59, with a median of 48761000.0 recorded in 2025.
- Year-over-year, Cash from Operations surged 61.92% in 2022 and sank 40.64% in 2025.
- Tracing NKTR's Cash from Operations over 5 years: stood at 57703000.0 in 2022, then increased by 18.47% to 47047000.0 in 2023, then rose by 1.83% to 46187000.0 in 2024, then slumped by 40.64% to 64959000.0 in 2025, then surged by 31.81% to 44298000.0 in 2026.
- The last three Cash from Operations figures came in at 44298000.0 (Q1 2026), 64959000.0 (Q4 2025), and 48761000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Nektar Therapeutics | 1.60 Bn | 1.04 Bn | 3.16 Mn | -44.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.30 Mn |
| Mar 31, 2026 | -44.30 Mn |
| Dec 31, 2025 | -64.96 Mn |
| Dec 31, 2025 | -64.96 Mn |
| Sep 30, 2025 | -48.76 Mn |
| Sep 30, 2025 | -48.76 Mn |
| Jun 30, 2025 | -45.74 Mn |
| Jun 30, 2025 | -45.74 Mn |
| Mar 31, 2025 | -49.05 Mn |
| Mar 31, 2025 | -49.05 Mn |
| Dec 31, 2024 | -46.19 Mn |
| Dec 31, 2024 | -46.19 Mn |
| Sep 30, 2024 | -43.93 Mn |
| Sep 30, 2024 | -43.93 Mn |
| Jun 30, 2024 | -37.70 Mn |
| Jun 30, 2024 | -37.70 Mn |
| Mar 31, 2024 | -47.89 Mn |
| Mar 31, 2024 | -47.89 Mn |
| Dec 31, 2023 | -47.05 Mn |
| Dec 31, 2023 | -47.05 Mn |
| Sep 30, 2023 | -42.12 Mn |
| Sep 30, 2023 | -42.12 Mn |
| Jun 30, 2023 | -51.52 Mn |
| Jun 30, 2023 | -51.52 Mn |
| Mar 31, 2023 | -51.92 Mn |
| Mar 31, 2023 | -51.92 Mn |
| Dec 31, 2022 | -57.70 Mn |
| Dec 31, 2022 | -57.70 Mn |
| Sep 30, 2022 | -82.89 Mn |
| Sep 30, 2022 | -82.89 Mn |
| Jun 30, 2022 | -74.99 Mn |
| Jun 30, 2022 | -74.99 Mn |
| Mar 31, 2022 | -88.42 Mn |
| Mar 31, 2022 | -88.42 Mn |
| Dec 31, 2021 | -151.54 Mn |
| Dec 31, 2021 | -151.54 Mn |
| Sep 30, 2021 | -101.14 Mn |
| Sep 30, 2021 | -101.14 Mn |
| Jun 30, 2021 | -82.90 Mn |
| Jun 30, 2021 | -82.90 Mn |
| Mar 31, 2021 | -77.09 Mn |
| Mar 31, 2021 | -77.09 Mn |
| Dec 31, 2020 | -98.63 Mn |
| Dec 31, 2020 | -98.63 Mn |
| Sep 30, 2020 | -52.68 Mn |
| Sep 30, 2020 | -52.68 Mn |
| Jun 30, 2020 | -83.90 Mn |
| Jun 30, 2020 | -83.90 Mn |
| Mar 31, 2020 | -78.08 Mn |
| Mar 31, 2020 | -78.08 Mn |
| Dec 31, 2019 | -125.22 Mn |
| Dec 31, 2019 | -125.22 Mn |
| Sep 30, 2019 | -68.64 Mn |
| Sep 30, 2019 | -68.64 Mn |
| Jun 30, 2019 | -53.92 Mn |
| Jun 30, 2019 | -53.92 Mn |
| Mar 31, 2019 | -80.90 Mn |
| Mar 31, 2019 | -80.90 Mn |
| Dec 31, 2018 | -117.55 Mn |
| Dec 31, 2018 | -117.55 Mn |
| Sep 30, 2018 | -71.41 Mn |
| Sep 30, 2018 | -71.41 Mn |
| Jun 30, 2018 | 959.64 Mn |
| Jun 30, 2018 | 959.64 Mn |
| Mar 31, 2018 | -52.47 Mn |
| Mar 31, 2018 | -52.47 Mn |
| Dec 31, 2017 | -80.40 Mn |
| Dec 31, 2017 | -80.40 Mn |
| Sep 30, 2017 | 93.08 Mn |
| Sep 30, 2017 | 93.08 Mn |
| Jun 30, 2017 | -58.52 Mn |
| Jun 30, 2017 | -58.52 Mn |
| Mar 31, 2017 | -34.57 Mn |
| Mar 31, 2017 | -34.57 Mn |
| Dec 31, 2016 | -52.41 Mn |
| Dec 31, 2016 | -52.41 Mn |
| Sep 30, 2016 | -27.36 Mn |
| Sep 30, 2016 | -27.36 Mn |
| Jun 30, 2016 | -13.60 Mn |
| Jun 30, 2016 | -13.60 Mn |
| Mar 31, 2016 | -23.65 Mn |
| Mar 31, 2016 | -23.65 Mn |
| Dec 31, 2015 | -75.11 Mn |
| Dec 31, 2015 | -75.11 Mn |
| Sep 30, 2015 | -14.03 Mn |
| Sep 30, 2015 | -14.03 Mn |
| Jun 30, 2015 | -47.26 Mn |
| Jun 30, 2015 | -47.26 Mn |
| Mar 31, 2015 | 63.31 Mn |
| Mar 31, 2015 | 63.31 Mn |
| Dec 31, 2014 | -24.63 Mn |
| Dec 31, 2014 | -24.63 Mn |
| Sep 30, 2014 | -46.00 Mn |
| Sep 30, 2014 | -46.00 Mn |
| Jun 30, 2014 | -9.09 Mn |
| Jun 30, 2014 | -9.09 Mn |
| Mar 31, 2014 | -62.29 Mn |
| Mar 31, 2014 | -62.29 Mn |
| Dec 31, 2013 | 53.63 Mn |
| Dec 31, 2013 | 53.63 Mn |
| Sep 30, 2013 | -19.71 Mn |
| Sep 30, 2013 | -19.71 Mn |
| Jun 30, 2013 | -34.34 Mn |
| Jun 30, 2013 | -34.34 Mn |
| Mar 31, 2013 | -38.11 Mn |
| Mar 31, 2013 | -38.11 Mn |
| Dec 31, 2012 | -47.38 Mn |
| Dec 31, 2012 | -47.38 Mn |
| Sep 30, 2012 | -27.17 Mn |
| Sep 30, 2012 | -27.17 Mn |
| Jun 30, 2012 | -20.59 Mn |
| Jun 30, 2012 | -20.59 Mn |
| Mar 31, 2012 | -34.62 Mn |
| Mar 31, 2012 | -34.62 Mn |
| Dec 31, 2011 | -42.21 Mn |
| Dec 31, 2011 | -42.21 Mn |
| Sep 30, 2011 | -21.87 Mn |
| Sep 30, 2011 | -21.87 Mn |
| Jun 30, 2011 | -34.79 Mn |
| Jun 30, 2011 | -34.79 Mn |
| Mar 31, 2011 | -14.87 Mn |
| Mar 31, 2011 | -14.87 Mn |
| Dec 31, 2010 | 20.41 Mn |
| Dec 31, 2010 | 20.41 Mn |
| Sep 30, 2010 | -22.16 Mn |
| Sep 30, 2010 | -22.16 Mn |
| Jun 30, 2010 | -19.95 Mn |
| Jun 30, 2010 | -19.95 Mn |
| Mar 31, 2010 | -34.16 Mn |
| Mar 31, 2010 | -34.16 Mn |